Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Glioblastoma represents the most aggressive primary malignant tumor of the central nervous system, characterized by extensive intratumoral heterogeneity, profound immunosuppression, therapeutic resistance, and poor clinical outcomes. Although immunotherapy has revolutionized cancer treatment, its clinical efficacy in GBM remains limited, largely due to the complexity of the tumor ecosystem and the lack of validated predictive biomarkers.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
